Brokerage Firm Rating on CVS Health Corporation (CVS)

CVS Health Corporation (CVS) has an average broker rating of 1.45, which is interpreted as a Strong Buy, as rated by 20 equity analysts. Nonetheless, 15 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 1 other analysts advise a Buy. Nevertheless, the majority of 4 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold.

CVS Health Corporation (CVS) : 21 Wall Street analysts covering CVS Health Corporation (CVS) believe that the average level the stock could reach for the short term is $111.88. The maximum price target given is $123 and the minimum target for short term is around $90, hence the standard deviation is calculated at $7.5.


For the current week, the company shares have a recommendation consensus of Buy. CVS Health Corporation (NYSE:CVS): The stock opened at $97.38 on Thursday but the bulls could not build on the opening and the stock topped out at $97.67 for the day. The stock traded down to $96.80 during the day, due to lack of any buying support eventually closed down at $97.00 with a loss of -0.11% for the day. The stock had closed at $97.11 on the previous day. The total traded volume was 3,870,861 shares.

In a related news, The director officer (President and CEO), of Cvs Health Corp, Merlo Larry J had unloaded 38,247 shares at $105 per share in a transaction on May 5, 2016. The total value of transaction was $4,015,935. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.